Inert pair
Inert Pair Effect is a concept in chemistry that explains the reluctance of the s-electrons of the outermost electron shell to participate in chemical bonding. This phenomenon is particularly observed in the heavier elements of groups 13 to 16 of the Periodic Table, where the valence shell consists of ns^2 np^x electrons. The "inert pair" refers to the ns^2 electrons which are not used for bonding in certain oxidation states of these elements.
Overview[edit | edit source]
The inert pair effect is a consequence of the relativistic stabilization of the s-orbital electrons. As the atomic number increases in a group, the nucleus becomes more positively charged, increasing the attraction between the nucleus and the valence electrons. This effect is more pronounced for the s-electrons due to their penetration and proximity to the nucleus, making them less available for bonding. This leads to the stabilization of lower oxidation states in heavier elements, which is a deviation from the expected trend based on simple electron counting.
Examples[edit | edit source]
A classic example of the inert pair effect can be seen in the group 13 element, thallium. While aluminum and gallium commonly exhibit a +3 oxidation state, thallium is more stable in the +1 oxidation state due to the inert pair effect. Similarly, in group 14, lead shows a preference for the +2 oxidation state over the +4 state, unlike its lighter counterparts such as tin and germanium.
Consequences[edit | edit source]
The inert pair effect has significant implications in various fields of chemistry, including inorganic chemistry, organometallic chemistry, and environmental chemistry. It influences the reactivity, stability, and types of compounds that can be formed by the heavier p-block elements. Understanding this effect is crucial for predicting the behavior of these elements in chemical reactions and for the design of new materials and catalysts.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD